Use of Darbepoetin Alfa for the Treatment of Chemotherapy-induced Anaemia in European Clinical Practice - Data From the CHOICE Study

被引：0
|
作者：
Van Belle, S. [1 ]
Galid, A. [2 ]
Karanikiotis, C. [3 ]
Wheeler, T. [4 ]
Pujol, B. [5 ]
Labourey, J. L. [6 ]
机构：
[1] Ghent Univ Hosp, B-9000 Ghent, Belgium
[2] Hanusch KH, Gynecol & Obstet, Vienna, Austria
[3] Euromed Kyanous Stavros Hosp, Theassaloniki, Greece
[4] Amgen Ltd, Int Dev, Uxbridge, Middx, England
[5] Amgen Europe, Int Dev, Zug, Switzerland
[6] Ctr Hosp Antoine Gayraud, Carcassonne, France
来源：
EUROPEAN JOURNAL OF CANCER | 2011年 / 47卷
关键词：
D O I：
10.1016/S0959-8049(11)71217-5
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S265 / S265
页数：1
相关论文
共 50 条
  • [21] A randomized, multicenter study of subcutaneous and intravenous darbepoetin alfa for the treatment of chemotherapy-induced anemia
    Justice, G
    Kessler, JF
    Jadeja, J
    Campos, L
    Weick, J
    Chen, CF
    Heatherington, AC
    Amado, RG
    ANNALS OF ONCOLOGY, 2005, 16 (07) : 1192 - 1198
  • [22] Darbepoetin alfa for the treatment of chemotherapy-induced anemia in patients with solid tumors
    Bustos, A.
    Carabantes, F.
    Alvarez, R.
    Diaz, N.
    Bueso, P.
    Lazaro, M.
    Gasquet, J. A.
    Alegre, A.
    EJC SUPPLEMENTS, 2009, 7 (02): : 197 - 197
  • [23] DARBEPOETIN ALFA VERSUS EPOETIN ALFA FOR TREATMENT OF CHEMOTHERAPY-INDUCED ANEMIA: A HEALTH ECONOMIC EVALUATION
    Finek, J.
    Holubec, L.
    Wiesnerova, A.
    Pav, Z.
    Dusek, L.
    TUMOR BIOLOGY, 2010, 31 : S102 - S103
  • [24] DARBEPOETIN ALFA VERSUS EPOETIN ALFA FOR TREATMENT OF CHEMOTHERAPY-INDUCED ANEMIA: A HEALTH ECONOMIC EVALUATION
    Finek, J.
    Holubec, L.
    Wiesnerova, A.
    Pav, Z.
    Dusek, V.
    ANNALS OF ONCOLOGY, 2010, 21 : 344 - 344
  • [25] Pharmacokinetic evaluation of darbepoetin alfa for the treatment of pediatric patients with chemotherapy-induced anemia
    Blumer, Jeffrey
    Berg, Stacey
    Adamson, Peter C.
    Loew, Thomas
    Rossi, Greg
    Hastings, Caroline
    PEDIATRIC BLOOD & CANCER, 2007, 49 (05) : 687 - 693
  • [26] Darbepoetin alfa: Impact on treatment for chemotherapy-induced anemia and considerations in special populations
    Vansteenkiste, J
    Poulsen, E
    Rossi, G
    Glaspy, J
    ONCOLOGY-NEW YORK, 2002, 16 (10): : 45 - 55
  • [27] A European patient record study on diagnosis and treatment of chemotherapy-induced anaemia
    Ludwig, Heinz
    Aapro, M.
    Bokemeyer, C.
    Glaspy, J.
    Hedenus, M.
    Littlewood, T. J.
    Osterborg, A.
    Rzychon, B.
    Mitchell, D.
    Beguin, Y.
    SUPPORTIVE CARE IN CANCER, 2014, 22 (08) : 2197 - 2206
  • [28] A European patient record study on diagnosis and treatment of chemotherapy-induced anaemia
    Heinz Ludwig
    M. Aapro
    C. Bokemeyer
    J. Glaspy
    M. Hedenus
    T.J. Littlewood
    A. Österborg
    B. Rzychon
    D. Mitchell
    Y. Beguin
    Supportive Care in Cancer, 2014, 22 : 2197 - 2206
  • [29] A EUROPEAN PATIENT RECORD STUDY ON DIAGNOSIS AND TREATMENT OF CHEMOTHERAPY-INDUCED ANAEMIA
    Mitchell, D.
    Aapro, M. S.
    Beguin, Y.
    Bokemeyer, C.
    Ludwig, H.
    Littlewood, T.
    Glaspy, J.
    Osterborg, A.
    Hedenus, M.
    ANNALS OF ONCOLOGY, 2010, 21 : 386 - 387
  • [30] Darbepoetin alfa - A review of its use in the treatment of anaemia in patients with cancer receiving chemotherapy
    Siddiqui, M. Asif A.
    Keating, Gillian M.
    DRUGS, 2006, 66 (07) : 997 - 1012
12345